Literature DB >> 18043253

Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.

Steven B Goldin1, Jason Aston, Monika M Wahi.   

Abstract

PURPOSE OF REVIEW: Pancreatic neuroendocrine tumors are rare neoplasms often associated with a clinical syndrome. Their rarity makes a comprehensive study difficult at any single institution, while their uniqueness makes them desirable for investigation. This review summarizes recent information and advancements concerning pancreatic neuroendocrine tumor diagnosis, imaging characteristics, treatment algorithms, and staging. RECENT
FINDINGS: Insulinomas and gastrinomas comprise the majority of functional pancreatic neuroendocrine tumors. Advances in their identification and diagnostic evaluation, imaging techniques, and treatment algorithms are presented. Furthermore, a new staging classification system has been proposed which may significantly improve the ability to conduct future multi-institutional investigations on pancreatic neuroendocrine tumors.
SUMMARY: Although rare, a thorough understanding of pancreatic neuroendocrine tumors is essential for all physicians due to the wide variety of symptoms with which patients present. Currently, patients are often misdiagnosed for extended periods of time. This review summarizes the recently published literature about diagnosis, imaging, treatment, and staging of pancreatic neuroendocrine tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18043253     DOI: 10.1097/CCO.0b013e3282f290af

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  5 in total

1.  Immunohistochemical investigation of F344/N rat islet cell tumors from national toxicology program studies.

Authors:  Christopher Koivisto; Gordon P Flake; Holly Kolenda-Roberts; Tiwanda Masinde; Grace E Kissling; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-04-03       Impact factor: 1.902

Review 2.  Non-surgical ablative therapies for inoperable benign insulinoma.

Authors:  C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo
Journal:  J Endocrinol Invest       Date:  2017-07-28       Impact factor: 4.256

3.  Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.

Authors:  Timothy R Donahue; Kevork K Kazanjian; William H Isacoff; Howard A Reber; O Joe Hines
Journal:  J Gastrointest Surg       Date:  2010-03-23       Impact factor: 3.452

4.  Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.

Authors:  Belén Pérez-Pevida; Miguel Ángel Idoate; Sara Fernández-Landázuri; Nerea Varo; Javier Escalada
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

5.  Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience.

Authors:  Andrey Germanovich Kriger; Stanislav Valer'evich Berelavichus; Ayrat Radikovich Kaldarov; Vladimir Igorevich Panteleev; David Semjonovich Gorin; Rimma Sangaevna Dugarova; Marina Yur'evna Yukina
Journal:  Gastrointest Tumors       Date:  2019-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.